Bumper Offer - Urjas oil Just @ Rs. 1
Cefadrox 125 Syrup DS, a prescription drug, is manufactured in various forms such as Syrup. It is typically used for the treatment of Bacterial Infections, Tonsillitis, Throat Infection. Secondary and off-label uses of Cefadrox 125 Syrup DS have also been mentioned below.
The optimal dosage of Cefadrox 125 Syrup DS is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Some other side effects of Cefadrox 125 Syrup DS have been listed ahead. Such side effects of Cefadrox 125 Syrup DS normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Cefadrox 125 Syrup DS is Safe for pregnant women and Safe for women who are breastfeeding. In addition, Cefadrox 125 Syrup DS's effects on the liver, heart and kidney are discussed below in the Cefadrox 125 Syrup DS related warnings section.
Some other conditions that can be affected by Cefadrox 125 Syrup DS are listed in the contraindications section below.
Drug reaction of Cefadrox 125 Syrup DS with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Cefadrox 125 Syrup DS is not safe while driving, and is is not addictive in nature.
Cefadrox 125 Syrup DS is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Cefadrox 125 Syrup DS is used -
Severe
Mild
Is the use of Cefadrox 125 Syrup DS safe for pregnant women?
Pregnant women can take Cefadrox safely.
Is the use of Cefadrox 125 Syrup DS safe during breastfeeding?
Breastfeeding women can safely use Cefadrox.
What is the effect of Cefadrox 125 Syrup DS on the Kidneys?
Cefadrox may have mild side effects on the kidneys.
What is the effect of Cefadrox 125 Syrup DS on the Liver?
Using Cefadrox does not have any harmful effects on the liver.
What is the effect of Cefadrox 125 Syrup DS on the Heart?
Cefadrox is not harmful for the heart.
Cefadrox 125 Syrup DS should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Cefadrox 125 Syrup DS unless your doctor advises you to do so -
Is this Cefadrox 125 Syrup DS habit forming or addictive?
Cefadrox 125 Syrup DS does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Cefadrox 125 Syrup DS, you should not drive or work on any heavy machine, as Cefadrox 125 Syrup DS can make you drowsy.
Is it safe?
Yes, Cefadrox 125 Syrup DS is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Cefadrox 125 Syrup DS in mental disorders is not effective.
Interaction between Food and Cefadrox 125 Syrup DS
It is safe to take Cefadrox 125 Syrup DS with food.
Interaction between Alcohol and Cefadrox 125 Syrup DS
You may consume alcohol while taking Cefadrox 125 Syrup DS. But caution is still important.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726